Effect of garlic on lipid profile and psychopathologic parameters in people with mild to moderate hypercholesterolemia

被引:0
作者
Peleg, A
Hershcovici, T
Lipa, R
Anbar, R
Redler, M
Beigel, Y
机构
[1] Bar Ilan Univ, Dept Criminol, Ramat Gan, Israel
[2] Rabin Med Ctr, Dept Med, Petah Tiqwa, Israel
[3] Rabin Med Ctr, Nutr & Dietet Unit, Petah Tiqwa, Israel
[4] Rabin Med Ctr, Lipid Unit, Petah Tiqwa, Israel
[5] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel
来源
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2003年 / 5卷 / 09期
关键词
garlic; lipid profile; psychological parameters;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The beneficial effect of 3-hydroxy-3-methylglutyaryl co-enzyme A reductase inhibitors on cardiovascular risk reduction has been clearly established. Concerns have been raised that lowering blood cholesterol by other hypolipidemic drugs or by a non-pharma-cologic approach may have deleterious effects on psychopathologic parameters. Garlic is one of the most commonly used herbal remedies and is considered to have hypocholesterolemic as well as other cardio-protective properties. Its effect on psychopathologic parameters has never been reported. Objectives: To evaluate the effect of garlic on lipid parameters and depression, impulsivity, hostility and temperament in patients with primary type 2 hyperlipidemia. Methods: In a 16 week prospective double-blind placebo-controlled study, 33 patients with primary hypercholesterolemia and no evidence of cardiovascular disease were randomly assigned to receive either garlic or placebo. Garlic in the form of alliin 22.4 mg/day was given to 13 patients, and placebo to 20. Both groups received individual dietary counseling. The changes in lipid profile and the various psychopathologic parameters were determined at the beginning and end of the trial. The differences in lipid parameters were evaluated by Student's t-test. The psychological data were analyzed by one-way analysis of variance (ANOVA) with repeated measures and Neuman-Keuls test. Results: No significant changes were observed in levels of total cholesterol, low density lipoprotein-cholesterol, high density lipoprotein-cholesterol and triglycerides, or in the psychopathologic parameters evaluated. Conclusion: Short-term garlic therapy in adults with mild to moderate hypercholesterolemia does not affect either lipid levels or various psychopathologic parameters.
引用
收藏
页码:637 / 640
页数:4
相关论文
共 25 条
[1]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[2]   Effects of hypocholesterolemic dietary and drug therapy on measures of dysphoric emotions [J].
Beigel, Y ;
Peleg, A ;
Assali, A ;
Nachshon, I .
EUROPEAN PSYCHIATRY, 1998, 13 (06) :288-294
[3]   Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism - A randomized controlled trial [J].
Berthold, HK ;
Sudhop, T ;
von Bergmann, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (23) :1900-1902
[4]  
BUSS A, 1957, J CONSULT CLIN PSYCH, V21, P353
[5]   CHOLESTEROL, PRIMARY AND SECONDARY PREVENTION, AND ALL-CAUSE MORTALITY [J].
CRIQUI, MH .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (12) :973-976
[6]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245
[7]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[8]   EFFECT OF DRIED GARLIC ON BLOOD-COAGULATION, FIBRINOLYSIS, PLATELET-AGGREGATION AND SERUM-CHOLESTEROL LEVELS IN PATIENTS WITH HYPERLIPOPROTEINEMIA [J].
HARENBERG, J ;
GIESE, C ;
ZIMMERMANN, R .
ATHEROSCLEROSIS, 1988, 74 (03) :247-249
[9]   DO CHOLESTEROL-LOWERING AGENTS AFFECT BRAIN ACTIVITY - A COMPARISON OF SIMVASTATIN, PRAVASTATIN, AND PLACEBO IN HEALTHY-VOLUNTEERS [J].
HARRISON, RWS ;
ASHTON, CH .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (03) :231-236
[10]  
KAPLAN J, 1999, PSYCHOSOM MED, V53, P634